Precigen (PGEN) Gross Margin (2013 - 2026)

Precigen (PGEN) reported Gross Margin of 88.99% for Q1 2026, up 7102.0% year-over-year from 1.24% in Q1 2025, and up 36.83% quarter-over-quarter from 65.04% in Q4 2025.

Precigen (PGEN) Gross Margin (2013 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Gross Margin data on file, last reported at 88.99% in Q1 2026.

  • Gross Margin for Q1 2026 came in at 88.99%, up 7102.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 77.44% (up 7618.0% YoY), and the FY2025 annual result was 50.2%, up 5891.0% from the prior year.
  • Gross Margin rose to 88.99% in Q1 2026 per PGEN's latest filing, from 65.04% in the prior quarter.
  • Over five years, Gross Margin peaked at 108.78% in Q4 2022 and troughed at 153600.0% in Q3 2023.
  • A 5-year average of 9838.52% and a median of 6.92% in 2022 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2023 and 2024: Gross Margin plunged 15360989 bps in 2023, then surged 15358612 bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 108.78% in 2022, then plunged by 110 bps to 10.59% in 2023, then soared by 281 bps to 19.21% in 2024, then surged by 239 bps to 65.04% in 2025, then soared by 37 bps to 88.99% in 2026.
  • Business Quant data shows PGEN's Gross Margin at 88.99% in Q1 2026, 65.04% in Q4 2025, and 3111.76% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 86.85%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 88.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 88.99%
Dec 31, 2025 65.04%
Jun 30, 2025 -3,111.76%
Mar 31, 2025 17.97%
Dec 31, 2024 19.21%
Sep 30, 2024 -13.88%
Jun 30, 2024 -50.67%
Mar 31, 2024 -678.99%
Dec 31, 2023 -10.59%
Sep 30, 2023 -153,600.00%
Jun 30, 2023 3.96%
Mar 31, 2023 -371.30%
Dec 31, 2022 108.78%
Sep 30, 2022 9.89%
Jun 30, 2022 37.79%
Mar 31, 2022 69.27%
Dec 31, 2021 128.29%
Sep 30, 2021 70.90%
Jun 30, 2021 88.57%
Mar 31, 2021 69.80%